{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:12:29Z","timestamp":1794607949261,"version":"4.9.1"},"reference-count":105,"publisher":"Elsevier","isbn-type":[{"value":"9780128183618","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.pmbts.2019.07.009","type":"book-chapter","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T08:03:29Z","timestamp":1565165009000},"page":"167-185","source":"Crossref","is-referenced-by-count":10,"title":["PD and DLB: Brain imaging in Parkinson's disease and dementia with Lewy bodies"],"prefix":"10.1016","author":[{"given":"Sarah B.","family":"Berman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Miller-Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6645","key":"10.1016\/bs.pmbts.2019.07.009_bb0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.07.009_bb0015","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.07.009_bb0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00702-017-1821-9","article-title":"Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies","volume":"125","author":"Jellinger","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"issue":"4 Movement Disorders","key":"10.1016\/bs.pmbts.2019.07.009_bb0030","first-page":"1117","article-title":"Diagnostic approach to atypical Parkinsonian syndromes","volume":"22","author":"McFarland","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.07.009_bb0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00004728-200203000-00018","article-title":"Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease","volume":"26","author":"Righini","year":"2002","journal-title":"J Comput Assist Tomogr"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.07.009_bb0040","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1212\/01.WNL.0000165960.04422.D0","article-title":"New and reliable MRI diagnosis for progressive supranuclear palsy","volume":"64","author":"Oba","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.07.009_bb0045","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/mds.26263","article-title":"Vascular Parkinsonism: deconstructing a syndrome","volume":"30","author":"Vizcarra","year":"2015","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1212\/WNL.58.4.575","article-title":"Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD","volume":"58","author":"Schocke","year":"2002","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.07.009_bb0055","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/01.WNL.0000049911.91657.9D","article-title":"Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy","volume":"60","author":"Seppi","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.07.009_bb0060","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e318284070c","article-title":"Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis","volume":"80","author":"Cochrane","year":"2013","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7861\/clinmedicine.16-4-371","article-title":"Imaging in Parkinson's disease","volume":"16","author":"Pagano","year":"2016","journal-title":"Clin Med (Lond)"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.07.009_bb0070","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2014.11.007","article-title":"Dopamine transporter imaging as a diagnostic tool for Parkinsonism and related disorders in clinical practice","volume":"21","author":"Ba","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0075","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","article-title":"Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.07.009_bb0080","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archneur.61.8.1224","article-title":"(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis","volume":"61","author":"Jennings","year":"2004","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0085","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.22108","article-title":"Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT","volume":"24","author":"Marshall","year":"2009","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0090","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.20748","article-title":"[123I]-FP\/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease","volume":"21","author":"Lorberboym","year":"2006","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0095","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/mds.25828","article-title":"Reversible dopamine transporter reduction in drug-induced parkinsonism","volume":"29","author":"Cilia","year":"2014","journal-title":"Mov Disord"},{"issue":"20","key":"10.1016\/bs.pmbts.2019.07.009_bb0100","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.0000000000000424","article-title":"Longitudinal follow-up of SWEDD subjects in the PRECEPT study","volume":"82","author":"Marek","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.07.009_bb0105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mds.10042","article-title":"Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP","volume":"17","author":"Kim","year":"2002","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.07.009_bb0110","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/mds.1256","article-title":"[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy","volume":"16","author":"Varrone","year":"2001","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.07.009_bb0115","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00259-004-1578-x","article-title":"Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy","volume":"31","author":"Knudsen","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.mnm.0000202858.45522.df","article-title":"123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study","volume":"27","author":"Filippi","year":"2006","journal-title":"Nucl Med Commun"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.07.009_bb0125","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s12149-014-0878-x","article-title":"Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson's disease and atypical parkinsonian syndromes using DaTSCAN(R) SPECT","volume":"28","author":"Davidsson","year":"2014","journal-title":"Ann Nucl Med"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.07.009_bb0130","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrneurol.2014.205","article-title":"Neuroimaging in Parkinson disease: from research setting to clinical practice","volume":"10","author":"Politis","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.07.009_bb0135","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mds.870130107","article-title":"123I-IBZM binding compared with long-term clinical follow up in patients with de novo parkinsonism","volume":"13","author":"Schwarz","year":"1998","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.07.009_bb0140","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s00259-007-0375-8","article-title":"Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism?","volume":"34","author":"Koch","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"10.1016\/bs.pmbts.2019.07.009_bb0145","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/WNL.0b013e31826c1b0a","article-title":"[(1)(8)F]FDG-PET is superior to [(1)(2)(3)I]IBZM-SPECT for the differential diagnosis of parkinsonism","volume":"79","author":"Hellwig","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archneur.1994.00540150027011","article-title":"Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data","volume":"51","author":"Sawle","year":"1994","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0155","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jnnp.57.3.278","article-title":"Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data","volume":"57","author":"Burn","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.07.009_bb0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s13139-012-0182-4","article-title":"Differential diagnosis of parkinsonism using dual-phase F-18 FP-CIT PET imaging","volume":"47","author":"Jin","year":"2013","journal-title":"Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.07.009_bb0165","first-page":"1760","article-title":"Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP\/SPECT and fluorine-18-FDOPA\/PET","volume":"37","author":"Ishikawa","year":"1996","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.07.009_bb0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00259-005-1904-y","article-title":"Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease","volume":"33","author":"Eshuis","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.07.009_bb0175","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1212\/WNL.57.11.2089","article-title":"[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression","volume":"57","author":"Marek","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.07.009_bb0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-510X(99)00127-6","article-title":"The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease","volume":"166","author":"Broussolle","year":"1999","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.07.009_bb0185","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamaneurol.2014.290","article-title":"Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography","volume":"71","author":"Hsiao","year":"2014","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.07.009_bb0190","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.25103","article-title":"Striatal dopamine in Parkinson disease: a meta-analysis of imaging studies","volume":"82","author":"Kaasinen","year":"2017","journal-title":"Ann Neurol"},{"issue":"10\u221212","key":"10.1016\/bs.pmbts.2019.07.009_bb0195","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s007020050124","article-title":"[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease","volume":"105","author":"Asenbaum","year":"1998","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.07.009_bb0200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s007020050004","article-title":"Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations","volume":"107","author":"de la Fuente-Fernandez","year":"2000","journal-title":"J Neural Transm (Vienna)"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.07.009_bb0205","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1212\/01.wnl.0000242888.30755.5d","article-title":"Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study","volume":"67","author":"Pavese","year":"2006","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/bs.pmbts.2019.07.009_bb0210","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/WNL.0b013e318292a31d","article-title":"Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD","volume":"80","author":"Loane","year":"2013","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/bs.pmbts.2019.07.009_bb0215","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/j.semnuclmed.2017.06.003","article-title":"Small-molecule PET tracers for imaging Proteinopathies","volume":"47","author":"Mathis","year":"2017","journal-title":"Semin Nucl Med"},{"key":"10.1016\/bs.pmbts.2019.07.009_bb0220","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40035-017-0076-6","article-title":"Imaging biomarkers in Parkinson's disease and parkinsonian syndromes: current and emerging concepts","volume":"6","author":"Saeed","year":"2017","journal-title":"Transl Neurodegener"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.07.009_bb0225","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acn3.644","article-title":"The Parkinson's progression markers initiative (PPMI)\u2014establishing a PD biomarker cohort","volume":"5","author":"Marek","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"24","key":"10.1016\/bs.pmbts.2019.07.009_bb0230","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson's disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.07.009_bb0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study","volume":"54","author":"Whone","year":"2003","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0240","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJMoa1809983","article-title":"Randomized delayed-start trial of levodopa in Parkinson's disease","volume":"380","author":"Verschuur","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0245","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.neuroimage.2005.03.012","article-title":"FDG PET in the differential diagnosis of parkinsonian disorders","volume":"26","author":"Eckert","year":"2005","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0250","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00234-012-1132-7","article-title":"Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography","volume":"55","author":"Tripathi","year":"2013","journal-title":"Neuroradiology"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.07.009_bb0255","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/01616412.2017.1312211","article-title":"The utility of FDG-PET in the differential diagnosis of parkinsonism","volume":"39","author":"Brajkovic","year":"2017","journal-title":"Neurol Res"},{"issue":"Pt 7","key":"10.1016\/bs.pmbts.2019.07.009_bb0260","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/awm086","article-title":"Changes in network activity with the progression of Parkinson's disease","volume":"130","author":"Huang","year":"2007","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.07.009_bb0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cpet.2009.12.004","article-title":"FDG PET in the evaluation of Parkinson's disease","volume":"5","author":"Poston","year":"2010","journal-title":"PET Clin"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0270","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1523\/JNEUROSCI.4188-09.2010","article-title":"Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease","volume":"30","author":"Tang","year":"2010","journal-title":"J Neurosci"},{"issue":"Pt 4","key":"10.1016\/bs.pmbts.2019.07.009_bb0275","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/brain\/aww005","article-title":"MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases","volume":"139","author":"Harper","year":"2016","journal-title":"Brain"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0280","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jalz.2018.09.011","article-title":"A signature pattern of cortical atrophy in dementia with Lewy bodies: a study on 333 patients from the European DLB consortium","volume":"15","author":"Oppedal","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.07.009_bb0285","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.3174\/ajnr.A5274","article-title":"MRI of the swallow tail sign: a useful marker in the diagnosis of Lewy body dementia?","volume":"38","author":"Shams","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.07.009_bb0290","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00234-016-1773-z","article-title":"Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study","volume":"59","author":"Kamagata","year":"2017","journal-title":"Neuroradiology"},{"issue":"Pt 7","key":"10.1016\/bs.pmbts.2019.07.009_bb0295","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/brain\/awh493","article-title":"Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study","volume":"128","author":"Bozzali","year":"2005","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.07.009_bb0300","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pscychresns.2007.01.001","article-title":"Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease","volume":"155","author":"Firbank","year":"2007","journal-title":"Psychiatry Res"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.07.009_bb0305","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pscychresns.2011.08.002","article-title":"Diffusion tensor imaging in Alzheimer's disease and dementia with Lewy bodies","volume":"194","author":"Firbank","year":"2011","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0310","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/nbm.1321","article-title":"Degeneration of dementia with Lewy bodies measured by diffusion tensor imaging","volume":"22","author":"Ota","year":"2009","journal-title":"NMR Biomed"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0315","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp.2009.184747","article-title":"A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies","volume":"81","author":"Lee","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"22","key":"10.1016\/bs.pmbts.2019.07.009_bb0320","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1212\/WNL.0b013e3181e0f7cf","article-title":"Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI","volume":"74","author":"Kantarci","year":"2010","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.07.009_bb0325","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jpsychires.2011.01.011","article-title":"White matter changes in dementia with Lewy bodies and Alzheimer's disease: a tractography-based study","volume":"45","author":"Kiuchi","year":"2011","journal-title":"J Psychiatr Res"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.07.009_bb0330","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1212\/WNL.0b013e318266fc51","article-title":"Characterizing dementia with Lewy bodies by means of diffusion tensor imaging","volume":"79","author":"Watson","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0335","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1017\/S1041610213002317","article-title":"Assessment of regional MR diffusion changes in dementia with Lewy bodies and Alzheimer's disease","volume":"26","author":"O'Donovan","year":"2014","journal-title":"Int Psychogeriatr"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.07.009_bb0340","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.neurobiolaging.2015.03.007","article-title":"White matter integrity in dementia with Lewy bodies: a voxel-based analysis of diffusion tensor imaging","volume":"36","author":"Nedelska","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/bs.pmbts.2019.07.009_bb0345","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fnagi.2015.00208","article-title":"Structural connectivity is differently altered in dementia with Lewy body and Alzheimer's disease","volume":"7","author":"Delli Pizzi","year":"2015","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.07.009_bb0350","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s002590100571","article-title":"Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease","volume":"28","author":"Ransmayr","year":"2001","journal-title":"Eur J Nucl Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.07.009_bb0355","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1192\/bjp.bp.114.148643","article-title":"Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: randomised study","volume":"206","author":"Walker","year":"2015","journal-title":"Br J Psychiatry"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0360","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.07.009_bb0365","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/01.WNL.0000123248.39847.1D","article-title":"Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison","volume":"62","author":"Walker","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.07.009_bb0370","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","article-title":"Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies","volume":"61","author":"O'Brien","year":"2004","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0375","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0000000000003512","article-title":"Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB","volume":"88","author":"Thomas","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0380","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.parkreldis.2011.09.015","article-title":"Diagnostic accuracy of (1)(2)(3)I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies","volume":"18","author":"Papathanasiou","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2019.07.009_bb0385","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jns.2015.11.004","article-title":"123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias","volume":"359","author":"Brigo","year":"2015","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.07.009_bb0390","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1017\/S1041610208007709","article-title":"A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies","volume":"20","author":"Colloby","year":"2008","journal-title":"Int Psychogeriatr"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.07.009_bb0395","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/jnnp-2012-302577","article-title":"Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT","volume":"83","author":"Morgan","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/bs.pmbts.2019.07.009_bb0400","doi-asserted-by":"crossref","first-page":"S754","DOI":"10.1002\/mds.22591","article-title":"Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies","volume":"24","author":"Walker","year":"2009","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0405","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00259-016-3466-6","article-title":"(123)I-FP-CIT SPECT findings and its clinical relevance in prodromal dementia with Lewy bodies","volume":"44","author":"Kasanuki","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2013-002642","article-title":"(123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study","volume":"3","author":"Siepel","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.07.009_bb0415","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.24825","article-title":"AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies","volume":"81","author":"Kantarci","year":"2017","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.07.009_bb0420","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jagp.2013.03.001","article-title":"Amyloid PET imaging in Lewy body disorders","volume":"23","author":"Donaghy","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.07.009_bb0425","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","article-title":"Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography","volume":"79","author":"Edison","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"20","key":"10.1016\/bs.pmbts.2019.07.009_bb0430","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.07.009_bb0435","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","article-title":"Tau positron emission tomographic imaging in the Lewy body diseases","volume":"73","author":"Gomperts","year":"2016","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.07.009_bb0440","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1038\/s41598-018-23041-x","article-title":"(18)F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies","volume":"8","author":"Smith","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/bs.pmbts.2019.07.009_bb0445","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/mds.27252","article-title":"Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases","volume":"33","author":"Lee","year":"2018","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0450","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/mds.27603","article-title":"(18) F-AV-1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy","volume":"34","author":"Nedelska","year":"2019","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/bs.pmbts.2019.07.009_bb0455","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.1133","article-title":"Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation","volume":"50","author":"Minoshima","year":"2001","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.07.009_bb0460","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2011.09.024","article-title":"Multimodality imaging characteristics of dementia with Lewy bodies","volume":"33","author":"Kantarci","year":"2012","journal-title":"Neurobiol Aging"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2019.07.009_bb0465","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(97)00713-1","article-title":"Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography","volume":"235","author":"Imamura","year":"1997","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.07.009_bb0470","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.51.1.125","article-title":"Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease","volume":"51","author":"Ishii","year":"1998","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.07.009_bb0475","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.109.065870","article-title":"The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies","volume":"50","author":"Lim","year":"2009","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.07.009_bb0480","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12149-017-1181-4","article-title":"Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT","volume":"31","author":"Imabayashi","year":"2017","journal-title":"Ann Nucl Med"},{"issue":"12","key":"10.1016\/bs.pmbts.2019.07.009_bb0485","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2967\/jnumed.114.143347","article-title":"18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias","volume":"55","author":"O'Brien","year":"2014","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/bs.pmbts.2019.07.009_bb0490","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1212\/WNL.0000000000000734","article-title":"Dementia with Lewy bodies: basis of cingulate island sign","volume":"83","author":"Graff-Radford","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/bs.pmbts.2019.07.009_bb0495","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.neurobiolaging.2014.01.001","article-title":"Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies","volume":"35","author":"Graff-Radford","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/bs.pmbts.2019.07.009_bb0500","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3233\/JAD-131517","article-title":"1H-proton magnetic resonance spectroscopy differentiates dementia with Lewy bodies from Alzheimer's disease","volume":"40","author":"Zhong","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"10.1016\/bs.pmbts.2019.07.009_bb0505","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1212\/01.WNL.0000141849.21256.AC","article-title":"1H MR spectroscopy in common dementias","volume":"63","author":"Kantarci","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/bs.pmbts.2019.07.009_bb0510","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ab.2016.12.022","article-title":"Glutathione in the human brain: Review of its roles and measurement by magnetic resonance spectroscopy","volume":"529","author":"Rae","year":"2017","journal-title":"Anal Biochem"},{"issue":"7","key":"10.1016\/bs.pmbts.2019.07.009_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/brainsci7070084","article-title":"Structural and functional neuroimaging of visual hallucinations in lewy body disease: a systematic literature review","volume":"7","author":"Pezzoli","year":"2017","journal-title":"Brain Sci"},{"issue":"1","key":"10.1016\/bs.pmbts.2019.07.009_bb0520","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2967\/jnumed.116.176180","article-title":"123I-Iodobenzovesamicol SPECT imaging of cholinergic Systems in Dementia with Lewy bodies","volume":"58","author":"Mazere","year":"2017","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/bs.pmbts.2019.07.009_bb0525","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/gps.4338","article-title":"Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study","volume":"30","author":"Shimada","year":"2015","journal-title":"Int J Geriatr Psychiatry"},{"issue":"10","key":"10.1016\/bs.pmbts.2019.07.009_bb0530","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1093\/cercor\/bhu220","article-title":"Thalamic involvement in fluctuating cognition in dementia with Lewy bodies: magnetic resonance evidences","volume":"25","author":"Delli Pizzi","year":"2015","journal-title":"Cereb Cortex"}],"container-title":["Progress in Molecular Biology and Translational Science","Brain Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117319301152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117319301152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T15:36:33Z","timestamp":1721576193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117319301152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128183618"],"references-count":105,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2019.07.009","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}